Global participants:Your ticket is your official entry pass for the ISAD Beijing 2026 meeting. Please present it at the check-in desk starting the afternoon of October 16th to receive your badge. What Your Ticket Contains: Need to Modify Any Information? If you need to update your details, please reach out directly to the appropriate contact: […]
Read MoreAccommodation at the China World Hotel Eligible Participants All participants who received a formal invitation letter by email from ISAD (info also displayed on your online e-ticket), including: Booking & Inquiries The China World Hotel will send your confirmation by email, and the information of your booking appears on your digital ticket. For questions or […]
Read More
ISAD Beijing 2026 Annual Meeting Final Preparations for the 16th Georg Rajka ISAD Symposium All registered participants will receive their personal electronic ticket via email between October 5 and 8, enabling them to fine tune their registration. Please remember to check your spam folder and contact us on October 9 if you have not received […]
Read More
9 picks this Month: Cardiovascular risk in AD: inflammation, lifestyle, or both? Sanabria-de la Torre R et al. Factors in Adults with Atopic Dermatitis: A Cross-sectional Study. Acta Derm Venereol. 2026;106:adv-2026-0452. ➜ DOI: 10.2340/actadv.v106.adv-2026-0452. Why it matters: The association between atopic dermatitis (AD) and cardiovascular disease remains debated, particularly regarding the respective roles of chronic inflammation [...] Read More
Deadline 1: September 30, 2026If your abstract has been accepted, you must accept your presentation slot and proofread your submission before the deadline. Follow these step-by-step instructions below to complete the process. Deadline 2: October 9, 2026The platform is now ready to receive your file, please check the instructions, and below: Step 1: Sign In […]
Read More
We are pleased to announce that the International Society of Atopic Dermatitis (ISAD) has been awarded a Research Networking Grant from the LEO Foundation to support the international scientific networking and consolidation workshop for Treat-to-Target in Atopic Dermatitis (T2T-AD) at the Rajka Symposium 2027 in Augsburg, Germany, building on preparatory steps initiated at Rajka Melbourne 2025 and continuing at […]
Read MoreAnnouncement If your submission has been selected for an oral presentation (in a plenary session or during a booth session), your travel grant is hereby awarded if you applied before the deadline. Please check if the reference of your abstract (#2—) is displayed in the program (plenary or booth sessions). For International applicants: Accommodation at […]
Read More
Periostin in atopic dermatitis: the “Purloined Letter” hiding in plain sight? Twenty years after linking periostin to IL-4/IL-13–driven airway remodeling in asthma [1], Izuhara and colleagues revisit a story they helped initiate [2]. The situation recalls Edgar Allan Poe’s The Purloined Letter, in which the object everyone is searching for escapes detection precisely because it […]
Read MoreAnnouncement If your submission has been selected for an oral presentation (in a plenary session or during a booth session), your travel grant is hereby awarded. Please check if the reference of your abstract (#2—) is displayed in the program. For International delegates: Accommodation at the China World Hotel is now included in the grant! […]
Read More
When “Severe AD” Is Not Just AD: Eczema as the First Sign of Inborn Errors of ImmunityAubert H et al. British Journal of Dermatology. 2026.➜ DOI: 10.1093/bjd/ljag308Why it matters:Among 373 patients with genetically defined inborn errors of immunity with atopy (IEIs-A), eczema affected 50.9%, often beginning in infancy and sometimes years before severe or unusual infections. [...] Read More